Global Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research

According to a new market report published by Transparency Market Research Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 – 2022”, the global NIPT market was valued at USD 0.53 billion in 2013 and is expected to expand at a CAGR of 17.5% from 2014 to 2022 to reach USD 2.38 billion in 2022.

Browse the full Non-invasive Prenatal Testing (NIPT) Market Report: http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

Non-invasive prenatal tests help in the detection of chromosomal aneuploidies (trisomy 18, trisomy 21, trisomy 13, monosomy X, etc.). Increasing demand for non-invasive prenatal tests is attributed to several benefits such as safety, sensitivity, and no risk of miscarriage during genetic screening. Increasing preference for late pregnancy (35 years and above) due to lifestyle and consistent modifications in the tests drive market growth. Advanced maternal age increases the risk of developing a fetus with certain chromosomal aneuploidies, thereby creating a huge demand for non-invasive prenatal tests. On the other hand, factors such as regulatory guidelines and ethical hurdles along with the need for invasive confirmatory prenatal tests could hamper market growth. The NIPT market could face ethical and regulatory hurdles associated with the implementation of NIPT because of the belief that it is likely to increase the incidence of abortions. Therefore, various professional organizations such as the American College of Obstetricians and Gynecologists (ACOG), the International Society for Prenatal Diagnosis and the Japan Society of Obstetrics and Gynecology, and genetic counselors around the world have strongly recommended the use of NIPT only in case of high-risk pregnancy.

According to the Centers for Disease Control and Prevention (CDC), nearly 700,000 pregnant women in the U.S. are at high risk of producing a child with chromosomal aneuploidies every year, representing a potential population base for NIPT. There are approximately 3.9 million births annually in the U.S. and approximately 377,886 births in Canada, representing target population for tests such as Harmony, Panorama, and VisibiliT.

Geographically, North America was the largest market for NIPT in 2013, accounting for a share of 58.8% in terms of revenue, followed by Asia Pacific. Significant presence of four major companies in the U.S. and launch of first NIPT in the country contributed to North America’s dominance in the NIPT market. MaterniT21 test was the first non-invasive prenatal test launched in the U.S. by Sequenom, Inc. and has recorded highest revenue and volume in North America compared to other tests. BambniTest was introduced by Berry Genomics, and the recent CFDA approval for the test would boost the growth of this test in Asia Pacific, both in terms of value and volume. InformaSeq non-invasive test was introduced by LabCorp in the U.S in 2014. Presently, this test is available only in the U.S. and is likely to be launched in other countries in the near future.

Browse the full Press Release of Non-invasive Prenatal Testing (NIPT) Market: http://www.transparencymarketresearch.com/pressrelease/noninvasive-prenatal-diagnostics-market.htm

The developers of NIPTs distribute these tests by collaborating with regional hospitals and diagnostic laboratories. Ariosa Diagnostics, Verinata Health (Illumina, Inc.), LabCorp, and Natera, Inc. are the major players operating in the NIPT market in North America. Increasing penetration by test developers in Europe, Asia-Pacific, and the Middle East indicates promising growth in these markets in the near future. BGI Diagnostics, LifeCodexx AG, Laboratoire Cerba, Natera, Inc., and Illumina Inc. have significant presence in Europe, while BGI Diagnostics and Berry Genomics dominate the NIPT market in Asia Pacific. NIPTs in countries such as Brazil and Mexico are available through hospitals and diagnostic laboratories such as Hospital Israelita Albert Einstein, DASA Group, and Fleury Group.

The global non-invasive prenatal testing market is segmented as follows:

Global Non-invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test
  • BambniTest
  • Harmony
  • informaSeq
  • MaterniT21 PLUS
  • NIFTY
  • Panorama
  • PrenaTest
  • verifi
  • VisibiliT
  • Others
Global Non-invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)\


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

OrthoSpace Raises US$ 8 million to Develop Innovative Rotator-cuff Treatment Device

OrthoSpace, a medical devices manufacturing company, which is currently engaged in the development of a minimally-invasive rotator-cuff treatment device, has managed to raise US$ 8 million from venture capitalists and investors. A sizeable chunk of the company’s fresh capital infusion comes from Healthpoint Capital, followed by Triventures (an existing investor) and Smith and Nephew (medical devices company). Xenia Venture Capital Ltd. also seized this opportunity by selling off US$2.15 million of its holdings in the company to Healthpoint Capital to make a profit to the tune of NIS 6.2 million.

The device being currently developed by OrthoSpace will serve as a support component for the shoulder in the case of server rotor cuff tears. Xenia, in a statement registered with Tel Aviv Stock Exchange (TASE), informed of this move.

OrthoSpace took root in a start-up incubator and was spun off from a company called BioProtect, which created a balloon that could separate tissue so radiation therapy could be performed on an enlarged prostate. This method helped prevent damage to healthy tissue surrounding the area. Experts later discovered that this technology could also be adapted for treating tears in the rotator-cuff.
The balloon serves as a buffer for the injured portion of the shoulder, helping reduce pain. As the tear begins to heal, the balloon degrades and ultimately averting the need for surgery. Founded on this basis in 2009, the company has thus far raised a considerable US$ 8.3 million not counting the latest investment. 

Triventures says that the company has been selling its product in the European market rather successfully and is expected to breakeven soon with thousands of procedures having successfully been performed. The CEO of OrthoSpace, Itay Barnea, feels that the company is now ready to consider going international.

North America Ground Mount PV Utility Market Capacity Installation is Estimated to Reach 17,589.7 MW by 2022: Transparency Market Research


Transparency Market Research has released a new market research report titled Ground Mount PV Utility Market by Installation (Pile Mount, Pole Mount, and Others) and by Country (U.S., Canada, and Mexico) – North America Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2022. According to the report, the ground mount PV utility annual installation in North America stood at 3,381.4 MW in 2013 and is expected to reach 17,589.7 MW by 2022, expanding at an AAGR of 20.1% between 2014 and 2022. Revenue generated through installations of ground mount PV utility projects in North America was valued at USD 7,311.8 million in 2013 and is projected to reach USD 19,464.1 million by 2022 at an AAGR of 11.5% between 2014 and 2022.

Browse the full report North America Ground Mount PV Utility Market: http://www.transparencymarketresearch.com/north-american-ground-mount-pv-utility-market.html
The solar PV industry in North America is gaining momentum is one of the promising renewable energy generation technology markets. The solar PV market in North America and across the globe is persistently growing towards competitiveness in the electricity sector. Fall in the prices of solar PV component, system, and technologies accompanied by rising electricity prices have assisted in achieving grid parity chiefly in North America. Government support has been instrumental in the progress of the utility-scale solar PV market in North America. Tax incentives and stimulus funded by the government have helped in increasing the installations of utility-scale solar PV in North American countries. Particularly the U.S. individual states in the country have also played a key role in increasing the adoption of renewables, including solar through the renewable portfolio standards (RPS). Additionally, financial incentives in the form of rebates and tax credits and exemptions are also being provided by the states, which would boost growth in the utility scale solar PV industry.

The ground mount utility market in North America, based on country-wise segment, has been divided into the U.S., Canada, and Mexico. The cumulative installations of utility-scale solar projects in the U.S. were estimated to be about 8 GW by 2014. The utility-scale projects are increasingly becoming economically-sound in comparison to other renewables including wind power, particularly in the desert southwest and California. This is anticipated to fuel additional growth in the ground mount PV utility market in North America.


The U.S. accounted for the highest installations of ground mount PV utility in 2013 and is expected to continue to dominate the market over the forecast period. Growth in the ground mount PV utility market in the U.S. is driven by technological innovations, tax incentives, and government grants for utility-scale PV projects. The installation of utility-scale projects is expected to generate clean electricity and help the nation meet its low-carbon energy targets. Rapidly growing demand for energy coupled with the cost of replacing aging power generation units is encouraging the development of renewable energy. Canada is a developing solar market and solar represents about 1% of the total electricity generated in the country. Canada’s solar industry is growing at a rapid pace as it exhibits increase in solar PV installations and reduction in costs. The financial support at various levels by the government for the development of both solar PV and ground mount projects would result in higher growth in the market for ground mount solar PV utility in Canada in the near future.

Companies across the region are adopting the strategy of forward and backward integration, thereby providing turnkey solutions to customers. Mounting systems manufacturers are strategically integrating to provide installation and racking solutions. Key participants in the ground mount PV utility market in North America include Andalay Solar, Inc., First Solar, Haticon Solar, LLC, NextEra Energy Resources, LLC, SolarCity Corporation, SunEdison, Inc., SunLink Corporation, SunPower Corporation, and Unirac Incorporated. This report provides an overview of these companies, followed by their financial revenues, business strategies, and recent developments. The ground mount PV utility market in North America has been segmented as follows:

North America Ground Mount PV Utility Market: Installation Type Analysis
o   Pile Mount
o   Pole Mount
o   Others

North America Ground Mount PV Utility Market: Country-wise Analysis
o   U.S.
o   Canada
o   Mexico

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Respiratory Disease Testing Market Expected to Reach USD 3.1 Billion Globally in 2022: Transparency Market Research

According to a new market research report published by Transparency Market Research “Respiratory disease Testing Market (By Tests – Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and Other Tests); (By End-User – Hospitals, Physician Offices and Clinical Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2022”, the global respiratory disease testing market was valued at USD 2.3 billion in 2013 and is estimated to reach USD 3.1 billion in 2022, expanding at a CAGR of 3.4% from 2014 to 2022.

Browse the full Respiratory Disease Testing Market Report: http://www.transparencymarketresearch.com/respiratory-disease-testing.html

Respiratory disease is a medical condition affecting the structure and organs associated with respiration or breathing (respiratory system). Based on anatomical features, the respiratory system is classified into upper respiratory tract and lower respiratory tract, comprising pharynx, larynx, and nasal passages, trachea, lungs, and bronchi. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, COPD, cystic fibrosis, and pneumonia. Moreover, the growing high-risk geriatric population and technological advancements would increase demand for respiratory disease testing products globally. However, low adoption rate of advanced equipment due to high cost and limited applications are the factors that restrict demand for respiratory equipment.


Geographically, North America was the largest market for respiratory disease testing in 2013 and the region is anticipated to maintain its dominance by the end of 2022. The region accounted for the largest share of the global market in 2013. Dominance of North America was due to increasing prevalence of respiratory diseases, rising popularity, adoption of portable devices, and growing demand for home health care devices and services. The Centers for Disease Control and Prevention (CDC) stated in 2012 that around 18.7 million adults in the U.S. were suffering from asthma, which constitutes a considerable portion of the overall addressable population. Moreover, the American Lung Association states that COPD is the third leading cause of death in the U.S. Rising demand for technologically advanced and innovative products in hospitals, diagnostic laboratories, and outpatient ambulatory surgery centers would fuel market growth in the region.

Europe accounted for the second largest share of the global respiratory disease testing market. However, Asia-Pacific is expected to expand at the highest CAGR from 2014 to 2022. This growth is mainly attributed to factors such as untapped opportunities, developing health care infrastructure, and increasing awareness about the available diagnostic procedures. For instance, according to the Central Bureau of Health Intelligence (India), the number of government hospitals in India increased from 4,571 in 2000 to 11,993 in 2011. Rapidly increasing number of hospitals has led to the growth in demand for radiology examination devices in hospital and laboratory settings, which is driving the respiratory disease testing market.

The respiratory disease testing market in Latin America is likely to expand at a significant CAGR from 2014 to 2022. Improving health care scenario, rising prevalence of respiratory diseases, and growing investments by market players are the major factors fueling the growth of the respiratory disease testing market in Latin America. Brazil and Mexico are driving the respiratory disease testing market in the region due to favorable initiatives taken by the respective governments for disease prevention and control, and thus improve the overall health and well-being of the general population. Moreover, improving health care infrastructure would fuel market growth in Latin America. However, lower adoption of modern, technologically advanced devices due to higher costs could hinder market growth in the region. In addition, stringent regulations by the government on the import of refurbished medical devices in Brazil are deterring vendors to enter the market.

CareFusion Corporation (Complete PFT), Carestream Health, Inc. (CARESTREAM DRX-1 System), Cosmed (Quark SPIRO), GE Healthcare (Discovery XR656 Plus), and Perkin Elmer, Inc. (Flat panel X-ray detectors) are the key players that have marked their presence in the global respiratory disease testing market.



The global respiratory disease testing market is segmented as follows:
§Global Respiratory Disease Testing Market, by Test
o   Imaging Tests
o   Spirometry Tests
o   Peak Flow Tests
o   Blood Gas Tests
o   Lung Volume Tests
o   Other Tests
§Global Respiratory Disease Testing Market, by End-user
o   Hospitals
o   Physician Offices
o   Clinical Laboratories
  Global Respiratory Disease Testing Market, by Geography
o   North America
o  U.S.
o  Canada
o   Europe
o  U.K.
o  Germany
o  Rest of Europe
o   Asia-Pacific (APAC)
o  Japan
o  China
o  Rest of APAC
o   Latin America (LATAM)
o  Brazil
o  Mexico
o  Rest of LATAM
o   Middle East North Africa (MENA)
o  Saudi Arabia
o  UAE
o  Rest of MENA
o   Rest of the World

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Dow Microbial Control Joins Esteemed bluesign System


Dow Microbial Control, a business unit of the Dow Chemicals Company, has announced that it is now a part of the bluesign system – a network of leading prominent market players that offer services to apparel and textiles industries globally.

Bluesign Technologies AG, a Swiss firm, manages the bluesign system. The company works in close association with supply chain stakeholders to ensure the safety of chemicals and materials that go into the making of apparel and textiles. The company’s three-pronged focus lies on consumers, industry workers, as well as the environment.

The bluesign system conducts periodic reviews of the progress made by chemical manufacturers who are a part of the system through their corporate reports. On-site audits of partners’ manufacturing units are also conducted by the firm.

The system emphasizes performance enhancement across five spheres: Air emissions, occupational health and safety, consumer safety, water emissions and resource productivity. In September 2012, Dow Microbial Control had introduced an antimicrobial product called SILVADUR, especially for apparel and textiles applications. The antimicrobial product was received well on account of its ability to provide extended freshness to apparel and textiles. The product also did well because customers are ostensibly adopting a healthier lifestyle and this change has percolated all the way to their apparel choices.

SILVADUR was formulated based on patented technology called Intelligent Freshness, which renders better odor control in clothing and textile by neutralizing odor-causing bacteria on the fabric’s surface. According to a number of tests conducted in the past, SILVADUR Antimicrobial boasts higher efficiency as compared to other such products on the market, and lasts even after 50 washes.

Irish Government Pumps in €5 million to Boost Technology in Healthcare Delivery with New Center


The government of Ireland has decided to make a €5 million investment in to bring about a change in the way healthcare services in the country are currently delivered. The Applied Research for Connected Health Technology Centre will play an integral role in this transformation.

ARCH, which is based in the University College Dublin, will see researchers from a myriad of branches collaborate on connected health projects. The team of researchers will feature experts from engineering, policy and economics, clinical and technology. The project will receive inputs from the University of Limerick as well as a number of other institutes that provide higher education. Simply stated, the project will see all leading institutes with connected healthcare capabilities collaborate on this ambitious project. 

Connected health entails the use of connecting technologies (such as the internet and mobile phones) to deliver healthcare applications and treatments in a novel manner. Moving forward, the internet of things concept will also play a central role in healthcare delivery, and the Irish government is already taking measures to be prepared for this technological change.

This multi-million euro project will see copious use of technologies such as alarm systems, sensors, monitoring devices, data management systems and health informatics being integrated on a much wider scale in the country’s existing healthcare systems.

According to Richard Bruton, Ireland’s Jobs, Enterprise and Innovation minister, the healthcare industry is key to the growth of the country, and forms an integral part of the Action Plan for Jobs – a program that aims to increase employment numbers in the country. 

The minister said besides bringing the best research talent and industry representatives together, technology center is being considered as an effective way to create more jobs in the area surrounding it. Over the next few months, the program is expected to introduce innovative technologies and models that can be seamlessly implemented in the Irish healthcare industry.

Viet Nam Reports High Export Turnover from FDI in 2014, More Foreign Players Expected to Venture In Soon

A latest report released by the Viet Nam Electronic Industries Association states that the highest share in the country’s total export incomes came from foreign direct investment (FDI). This is an interesting revelation considering that FDI enterprises comprise only about a third of all electronics enterprises in Viet Nam. The country has made rapid progress in the electronics industry, which has largely been propelled by initiatives to attract more foreign investors, a report in a leading newspaper in the country quoted the Association’s chairman as saying

Turnover from the exports of telephones and auxiliary components from Vietnam stood at US$24.1 billion in 2014, marking an increase of 13.4% as compared to the previous year. Remarkably, within the FDI sector, the total expert turnover from telephones and space components stood at a staggering 99.6%. Likewise, the values of computers, exported electronics and spare parts in 2014 approximated US$11.6 billion. About 98.8% of this turnover can be traced back to the FDI sector.

Companies that have contributed to a lion’s share of the total export turnover are: Samsung Electronics (which has multiple factories in Viet Nam), Morips Vina, KSD Vina Company, and Orientech Vina. In the meanwhile, there have been reports that other leading companies such as LG and Canon are also vying to capitalize on the opportunities that exist in Viet Nam and are pumping in more investment dollars into the country. 

These developments could easily turn Viet Nam into one of the leading mobile phone manufacturing countries in the world. The country is also a leading base for printer manufacturing and photocopy machines. With the projected expansion in the size of the electronics industry in Viet Nam, component manufacturers will be compelled to beef up their investments here.

But this also raises questions about the domestic manufacturers in Viet Nam will be able to cope with the influx of global players. Finally, with import taxes being high, the electronics industry in Viet Nam may not get the launch pad it is looking for.

Latest Post

Market Research Reports